Pristimerin inhibits the progression of antibody-induced autoimmune arthritis

H Nanjaiah,KD Moudgil
DOI: https://doi.org/10.1080/03009742.2024.2421618
2024-11-17
Scandinavian Journal of Rheumatology
Abstract:Objectives Rheumatoid arthritis (RA) is an autoimmune disease of the synovial joints. Pro-inflammatory cytokines produced by various immune cells drive the chronic inflammatory processes that lead to joint damage. Many drugs are available for the treatment of RA, but a significant proportion of patients do not respond adequately to them and/or have severe adverse effects. Accordingly, there is an urgent need for new therapeutics for RA. Therefore, we tested pristimerin, a natural triterpenoid, for its anti-arthritic activity in experimental RA.
rheumatology
What problem does this paper attempt to address?